Ishami Mpuzamahanga

Mu rwego mpuzamahanga rwo gusuzuma no kuvura kanseri y'ibihaha, kumenya no kuvura neza utubyimba tw'ibihaha byagiye biba ari byo byibandwaho n'abaganga. Nk'igicucu cyimbitse mu gupima ibihaha, utubyimba tw'ibihaha turatandukanye, kuva ku kubyimba guke kugeza ku ma...Soma byinshi»

Mu rugendo rwo kurwanya kanseri, umuryango w’abaganga wakomeje gushaka uburyo bwiza kandi bwizewe bwo kuvura. Nubwo kubaga, gukoresha imirasire, imiti ivura kanseri, na biotherapy byashyizeho urufatiro rukomeye rwo kuvura kanseri, hyperthermia—ikoranabuhanga rigezweho rikomoka ku bwenge bwa kera—...Soma byinshi»

Mu gihe abarwayi bahuye n'indwara ya kanseri, icyizere rusange cy'abarwayi ku isi yose ni ukubona uburyo bwiza bwo kuvura, bugezweho kandi budatera indwara nyinshi. Niba ushaka ibitaro bihuriza hamwe ubuhanga bwo mu buvuzi bw'Abashinwa, ikoranabuhanga rigezweho, na serivisi zisanzwe ku rwego mpuzamahanga, ...Soma byinshi»

Iyo wowe cyangwa uwo ukunda ahuye n'indwara ya kanseri kandi ukumva ufite intege nke cyangwa nta byiringiro mu gihe ushaka uburyo bwo kuvura mu gace utuyemo, ese wibaza uti: Ku rundi ruhande rw'isi, hari uburyo bwo kuvura buteye imbere, budatera indwara nyinshi, kandi bufite icyizere? Ku bibazo bijyanye n'ubuvuzi bushya bwa kanseri...Soma byinshi»

Umurwayi wa kanseri yo mu bwonko wari warasubiye kurwara nyuma y’ubuvuzi bwa CAR-T inshuro 17, ikibyimba cye cyarazimye burundu mu byumweru 4 nyuma yo guhabwa ubuvuzi bushya bwa TIL kandi yamaze amezi arenga 20 nta kibyimba afite. Ku bibazo bijyanye n’ubuvuzi bushya bwa kanseri n’igeragezwa ry’ubuvuzi: Terefone: 4008803716 | WeChat:...Soma byinshi»

Ku ya 17 Ugushyingo 2025, Abbisko yatangaje ku rubuga rwa posteri igaragaza imikorere myiza y'igihe kirekire, umutekano n'ibyavuye mu bushakashatsi ku barwayi bwakozwe ku rwego rw'isi ku cyiciro cya gatatu cya MANEUVER kuri pimicotinib (ABSK021) ku barwayi bafite tumour y'uturemangingo twinshi twa tenosynovial (TGCT) mu ishyirahamwe ryita ku barwayi ba kanseri y'uturemangingo (CTOS) 2025 ...Soma byinshi»

Ku ya 8 Nzeri 2025, InnoCare Pharma yatangaje ko HIBRUKA (orelabrutinib) yemejwe n'Ikigo gishinzwe ubumenyi bw'ubuzima (HSA) cyo muri Singapuru mu kuvura abarwayi bakuru bafite uburwayi bwo gusubira inyuma cyangwa budashobora kugaragara neza (R/R MZL). Kuri ubu, haracyari igeragezwa ryinshi ry’indwara nshya...Soma byinshi»

Ku ya 28 Kanama, Ikigo gishinzwe Isuzuma ry'Imiti (CDE) cy'Ikigo cy'Igihugu gishinzwe Ibikoresho by'Ubuvuzi (NMPA) cyatangaje ko BL-B01D1 yo guterwa inshinge iteganijwe gushyirwa mu isuzuma ry'ibanze. Igenewe abarwayi ba kanseri yo mu nda isubira cyangwa yanduye kandi bafite ikibazo cyo kurwara kanseri mbere y'uko...Soma byinshi»

Ku itariki ya 21 Kanama, epcoritamab, yahawe uburenganzira bwo gusuzuma imiti ikoreshwa mu ishami ry’ubuvuzi (Center for Drug Evaluation (CDE)) ku itariki ya 21 Kanama. Ubu buryo bwemewe bugenewe abarwayi bakuru bafite uburwayi bwa follicular lymphoma (FL) yasubiwemo cyangwa idashobora guhindurwa, ikaba ari ikibazo gikomeye...Soma byinshi»

Ku itariki ya 29 Kanama, imiti ya Boehringer Ingelheim's HERNEXEOS® (ibinini bya zongertinib) yemejwe nk'umuti umwe n'Ikigo cy'Igihugu cy'Ubuvuzi mu Bushinwa (NMPA) mu kuvura abarwayi bakuru bafite kanseri y'ibihaha idakira, iteye imbere cyangwa isanzwe idakira (NSCLC) ifite ibibyimba ...Soma byinshi»

Ku ya 22 Kanama 2025, Datopotamab deruxtecan (Dato-DXd; Datroway) yemerewe mu Bushinwa kuvura abarwayi bakuru bafite imisemburo idakira cyangwa itera metastatic hormone receptor-positive, HER2-negative (immunohistochemistry [IHC] 0, IHC 1+, cyangwa IHC 2+/in situ hybridization [ISH] negative) ...Soma byinshi»

Muri Kanama 2025, Ikigo gishinzwe Isuzuma ry'Imiti (CDE) cy'Ikigo cy'Igihugu gishinzwe Ibikoresho by'Ubuvuzi (NMPA) cyemereye ku mugaragaro Itangwa ry'Ubuvuzi bwa Breakthrough kuri Ina-cel, uburyo bushya bwo kuvura uturemangingo twa CAR-T buyobowe na CD19 bwakozwe na Juventas ku giti cyabo, kugira ngo buvure abarwayi b'abana bafite ...Soma byinshi»